AZD8965
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
AstraZeneca
Overview
AZD8965 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
AZD8965 clinical trials
Explore related
Medical disclaimer. This page summarizes research about AZD8965 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.